Redeye provides a research update on Lipum following the Q3 report published by the company earlier today. We make some minor adjustments to our estimates following a lower cash burn than expected. However, we reiterate our fair value range (SEK4 – SEK32) with a base case valuation of SEK20 as we continue to have a positive outlook on the case.
LÄS MER